Dark genome cancer biology and bioinformatics

Nearly half of our DNA is made of transposable elements: ancient viral remnants and sequences that once copied themselves around the genome. We study what they do in cancer and blood disorders, and how they can help predict and treat disease.

  • Endogenous retroviruses
  • LINEs
  • SINEs
  • Protein-coding genes

Dark genome cancer biology

Transposable elements are usually kept silent, but in cancer they can switch back on. We map when and where this happens, which epigenetic pathways fail to hold them back, and how their activity shapes gene expression, inflammation and the immune response.

Because reactivated elements can produce new protein sequences, they are also a source of potential targets for T cell and antibody-based therapies.

Bioinformatics

Much of the dark genome is repetitive and hard to measure with standard pipelines. We build computational methods to quantify transposable element activity from sequencing data and integrate it with genomic, epigenomic and clinical information.

We use machine learning and visual analytics to turn these multi-omics datasets into predictive models, with a focus on haematological malignancies such as acute myeloid leukaemia.